Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

3.4K
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From architecture to function: mechanisms shaping pancreatic islet morphogenesis.

Trends in endocrinology and metabolism: TEM·2026
Same author

Real-time, label-free impedimetric monitoring of insulin secretion from three-dimensional stem cell-derived islets.

Biosensors & bioelectronics·2026
Same author

TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network.

Nature communications·2026
Same author

ΔNP63 Defines an Exocrine-committed Subset of Murine Pancreatic Progenitor Cells.

Cellular and molecular gastroenterology and hepatology·2025
Same author

Discovery of a pre-vein progenitor that requires VEGF/ERK inhibition to complete vein differentiation.

bioRxiv : the preprint server for biology·2025
Same author

Benchmarking porcine pancreatic ductal organoids for drug screening applications.

EMBO molecular medicine·2025

Related Experiment Video

Updated: May 1, 2026

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

4.8K

Islet cell plasticity and regeneration.

Adriana Migliorini1, Erik Bader2, Heiko Lickert3

  • 1Institute of Stem Cell Research, Helmholtz Zentrum München, Ingolstädter Landstr. 1, D-85764 Neuherberg, Germany ; Institute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Am Parkring 11, D-85748, Business Campus Garching, Germany.

Molecular Metabolism
|April 22, 2014
PubMed
Summary
This summary is machine-generated.

Restoring pancreatic beta-cell function is key for diabetes treatment. Promising strategies include increasing beta-cell replication and converting alpha-cells into beta-cells for improved metabolic control.

Keywords:
DiabetesIslet architecturePancreas plasticityβ-cell neogenesisβ-cell proliferationβ-cell regeneration

More Related Videos

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.6K
Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.7K

Related Experiment Videos

Last Updated: May 1, 2026

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

4.8K
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

2.6K
Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.7K

Area of Science:

  • Endocrinology and Metabolic Diseases
  • Regenerative Medicine
  • Diabetes Research

Background:

  • Insulin-dependent diabetes mellitus (IDDM) involves beta-cell loss/dysfunction, leading to metabolic dysregulation.
  • While type 1 and type 2 diabetes have different causes, restoring beta-cell function is a common therapeutic goal.
  • Current treatments aim for beta-cell replacement or stimulating endogenous regenerative processes.

Purpose of the Study:

  • To review recent advancements in beta-cell regeneration strategies for diabetes.
  • To highlight promising approaches for restoring beta-cell mass and function.
  • To discuss therapeutic avenues for both type 1 and type 2 diabetes.

Main Methods:

  • Literature review of current research in beta-cell regeneration.
  • Analysis of studies focusing on enhancing beta-cell self-replication and neogenesis.
  • Examination of research on alpha-cell to beta-cell conversion.

Main Results:

  • Beta-cell regeneration offers potential for improved diabetes therapy.
  • Key strategies involve stimulating intrinsic pancreatic regenerative mechanisms.
  • Promising approaches include increasing beta-cell replication/neogenesis and alpha-cell transdifferentiation.

Conclusions:

  • Restoring beta-cell function is crucial for managing insulin-dependent diabetes.
  • Cell-replacement therapy combined with immunosuppression is a potential cure for type 1 diabetes.
  • Enhancing endogenous regeneration, such as increasing beta-cell replication or alpha-cell conversion, may optimize type 2 diabetes management.